Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients. 1987

F Brun-Vezinet, and M A Rey, and C Katlama, and P M Girard, and D Roulot, and P Yeni, and L Lenoble, and F Clavel, and M Alizon, and S Gadelle

Lymphadenopathy-associated virus type 2 (HIV 2) was isolated from 3 patients with AIDS and 1 with AIDS-related complex. Clinical features were similar to those in patients infected with HIV 1. Viral isolates were characterised by hybridisation with HIV 1 and HIV 2 DNA probes. HIV 1 and HIV 2 serological studies were performed by enzyme-linked immunosorbent assay (ELISA), western blot, and radioimmunoprecipitation assay. HIV 2 IgG antibodies were detected in all sera. The molecular weights of the most representative HIV 2 proteins were determined by immunoblot. Cross-reactivity was restricted to HIV 1 and HIV 2 core proteins. In all 4 patients the neurotropism of HIV 2 was demonstrated by virus isolation from the cerebrospinal fluid and/or by evidence of intrathecal HIV 2 IgG synthesis. All sera were antibody negative by HIV 1 ELISA. An assay specific for HIV 2 is needed for screening of blood donations and for diagnosis and seroepidemiological study of HIV 2 infection.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F Brun-Vezinet, and M A Rey, and C Katlama, and P M Girard, and D Roulot, and P Yeni, and L Lenoble, and F Clavel, and M Alizon, and S Gadelle
November 1986, The Journal of infectious diseases,
F Brun-Vezinet, and M A Rey, and C Katlama, and P M Girard, and D Roulot, and P Yeni, and L Lenoble, and F Clavel, and M Alizon, and S Gadelle
September 1984, Lancet (London, England),
F Brun-Vezinet, and M A Rey, and C Katlama, and P M Girard, and D Roulot, and P Yeni, and L Lenoble, and F Clavel, and M Alizon, and S Gadelle
February 1987, The American journal of surgical pathology,
F Brun-Vezinet, and M A Rey, and C Katlama, and P M Girard, and D Roulot, and P Yeni, and L Lenoble, and F Clavel, and M Alizon, and S Gadelle
February 1995, AIDS research and human retroviruses,
F Brun-Vezinet, and M A Rey, and C Katlama, and P M Girard, and D Roulot, and P Yeni, and L Lenoble, and F Clavel, and M Alizon, and S Gadelle
July 1985, The New England journal of medicine,
F Brun-Vezinet, and M A Rey, and C Katlama, and P M Girard, and D Roulot, and P Yeni, and L Lenoble, and F Clavel, and M Alizon, and S Gadelle
September 1984, Lancet (London, England),
F Brun-Vezinet, and M A Rey, and C Katlama, and P M Girard, and D Roulot, and P Yeni, and L Lenoble, and F Clavel, and M Alizon, and S Gadelle
March 1985, The New England journal of medicine,
F Brun-Vezinet, and M A Rey, and C Katlama, and P M Girard, and D Roulot, and P Yeni, and L Lenoble, and F Clavel, and M Alizon, and S Gadelle
April 1995, Scottish medical journal,
F Brun-Vezinet, and M A Rey, and C Katlama, and P M Girard, and D Roulot, and P Yeni, and L Lenoble, and F Clavel, and M Alizon, and S Gadelle
December 1998, Revue neurologique,
F Brun-Vezinet, and M A Rey, and C Katlama, and P M Girard, and D Roulot, and P Yeni, and L Lenoble, and F Clavel, and M Alizon, and S Gadelle
October 2023, Virus research,
Copied contents to your clipboard!